THE HEART RESERVE PODCAST
Hormones & heart health5:08 min
Will Hormone Therapy Protect My Heart?
What hormone therapy can help, why timing and medical history matter, and what the studies do—and do not—show about preventing heart attacks.
HEART RESERVE · THE PODCAST
Your next
listen.
Narration uses Lisa’s authorized AI voice.
THE TAKEAWAYS
What I want you to understand
- Hormone therapy can help menopause symptoms. It is not recommended solely to prevent heart disease.
- Your age, time since menopause, and medical history matter to the decision.
- A change in an artery measurement is not the same as showing fewer heart attacks.
Episode chapters
- 0:00 The question behind the headlines
- 0:33 What treatment can actually help
- 1:23 Why timing matters
- 2:14 What one important study measured
- 3:14 What the recent guidance changes
- 4:14 The conversation to have
Read the full transcript
The question behind the headlines
One person tells you hormone therapy is dangerous. Someone else says every woman needs it to protect her heart.
Where does that leave you?
I'm Lisa, a physician assistant and the founder of Heart Reserve. Let's answer one question today. Will taking hormones for menopause prevent a heart attack?
We cannot promise that. Hormone therapy can be very helpful for menopause symptoms. Whether it is a good choice for you depends on what you're treating, your health history, and when you start.
You deserve to understand those pieces before you decide.
What treatment can actually help
Estrogen is one of the hormones that changes around menopause. Hormones are chemical messages that help different parts of the body work.
Some women have hot flashes or night sweats that keep waking them up. Others have vaginal dryness or discomfort.
Hormone treatment can help with these symptoms. But there are different kinds.
A patch or a pill may deliver estrogen throughout the body. A low-dose vaginal treatment mainly treats symptoms in that area. Those are different treatment decisions.
If you still have your uterus, the organ where a pregnancy grows, estrogen that works throughout the body usually needs another medicine to protect the uterus lining. That medicine is often progesterone.
You do not need to remember all the names. You should know what your prescription is meant to do, why that type was chosen, and what improvement to expect.
Why timing matters
Starting treatment close to menopause is different from starting it many years later.
For many otherwise healthy women with troublesome symptoms, the balance of benefit and risk is more favorable before age sixty or within ten years of menopause.
That is a starting point for a conversation. Your medical history still matters.
A previous blood clot, stroke, heart attack, or breast cancer needs careful review. The type of hormone, the dose, and whether it is taken as a pill or through the skin can matter too.
A patch may carry less blood-clot risk than an estrogen pill. Much of that comparison comes from studies that observed women using these treatments, rather than large trials assigning them to one or the other.
So, a patch should not be described as risk-free. Your care team should explain why it fits your situation.
What one important study measured
Let's look at a real study so you can see why the answer isn't a simple yes or no.
A trial called Elite included six hundred forty-three healthy women who had gone through menopause.
Researchers compared estrogen treatment with a look-alike pill that contained no active medicine. They studied women who were within six years of menopause and women who were ten or more years past it.
In the group closer to menopause, estrogen slowed the thickening of the wall of an artery in the neck. That benefit wasn't seen in the later group.
This is useful evidence that timing matters.
But the main measurement was the thickness of an artery wall. The trial did not establish that taking estrogen prevents heart attacks. Other measurements of the heart's arteries did not show a clear treatment benefit.
When you hear, this treatment protects your heart, ask what the study actually measured. Was it a blood test? A scan? Or fewer people having heart attacks?
That question helps you understand how strong the promise really is.
What the recent guidance changes
You may also have heard about changes to hormone warnings.
In February twenty twenty-six, the FDA approved changes to the most prominent warnings on six hormone therapy products.
A label change does not mean every woman should take hormones. It also doesn't turn every hormone product into a proven heart-attack prevention medicine.
And a new September twenty twenty-six statement from international women's health and heart organizations supports more individual decisions about menopause treatment.
It allows consideration of hormone treatment for symptoms in some women with existing disease affecting blood flow to the heart, after careful counseling. This is an area where advice from different professional groups can differ.
If that describes you, a menopause specialist and your heart care team should work through the decision together.
The statement also says hormone therapy is not recommended solely to prevent heart disease. Treatment for blood pressure and cholesterol still matters when it is needed.
The conversation to have
Here are three questions that make the appointment more useful.
Which symptoms are we treating, and what improvement should I expect?
How do my age, time since menopause, and health history affect this choice?
Why this type of treatment, and what is my separate plan for heart protection?
If you can't take hormones, or prefer not to, ask what other treatments could help your symptoms. You still deserve care.
And if you already take hormone therapy, use this information to have a conversation. Don't change your prescription based on a podcast.
I want you to feel comfortable asking your care team to slow down and explain. You are the person who has to live with the symptoms and the treatment.
The studies and transcript are included with this episode. Find our free resources at heart reserve dot blog.
I'm Lisa. This is Heart Reserve. Know your story. Build your reserve.
Research & further reading
- Joint FIGO/World Heart Federation position paper (September 2026). ↗
- The Menopause Society: 2022 hormone therapy position statement. ↗
- ACOG: Hormone Therapy for Menopause. ↗
- Hodis et al. ELITE randomized trial (2016). ↗
- FDA: Hormone therapy labeling changes, February 12, 2026. ↗
Episode notes prepared October 5, 2026. Research applies to the people and outcomes studied. General education; discuss testing and treatment with your own care team.